NATIONAL HEALTHCARE CORP
NHCBusiness Summary
National HealthCare Corporation (NHC) operates in the post-acute and senior healthcare services industry, providing skilled nursing, assisted living, independent living, behavioral health, homecare, and hospice services. The company operates in 9 states 1, primarily in the Southeastern and Midwestern United States. The industry is characterized by extensive regulatory oversight from federal and state agencies, including licensure, certification, and reimbursement rules under Medicare and Medicaid. Key structural forces include the shift toward value-based purchasing, the Patient-Driven Payment Model (PDPM) for skilled nursing, and the Patient-Driven Groupings Model (PDGM) for homecare, which tie reimbursement to patient condition and quality outcomes rather than volume of services. The Centers for Medicare and Medicaid Services (CMS) Five-Star Quality Rating System is a key competitive benchmark, and the industry faces ongoing labor shortages and inflationary pressures on operating costs.
NHC competes with hundreds of operators of post-acute healthcare services across its operating states, with no single operator dominating any market except for some small rural markets with limited competition 2. The company differentiates itself through a continuum of care that links skilled nursing facilities with senior living communities, home health, hospice, and behavioral health hospitals, aiming to obtain a competitive advantage 3. As of December 31, 2025, NHC's skilled nursing facilities achieved an average Five-Star Quality Rating of 3.83 4 versus the industry average of 2.95 5, with 62.5% 6 of its 80 7 skilled nursing facilities rated 4 or 5 stars compared to 38.6% 8 industry-wide. Competitors include not-for-profit, non-taxpaying, and governmental agencies that can finance capital expenditures on a tax-exempt basis and receive charitable contributions unavailable to NHC 9.
NHC generates revenue primarily through the operation of healthcare facilities and the provision of management, accounting, financial, and insurance services. In fiscal year 2025, 96.8% 10 of net operating revenues were derived from healthcare services (net patient revenues), while 3.2% 11 came from other sources including management fees, rental income, and insurance services. The company operates under a model that includes owned, leased, and managed facilities: as of December 31, 2025, NHC owned 43 12 skilled nursing facilities, leased 29 13, and managed 8 14; owned 19 15 assisted living facilities, leased 5 16, and managed 2 17; and owned 5 18 independent living facilities, leased 3 19, and managed 1 20. Recurring income streams include daily patient care payments from Medicare, Medicaid, managed care, and private pay sources, as well as management fees typically charged at 6% 21 of managed centers' net operating revenues. The company also operates an Institutional Special Needs Plan (I-SNP) called NHC Advantage, a managed care insurance company that receives a per member, per month premium from Medicare 22.
NHC's inpatient services segment includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and behavioral health hospitals. As of December 31, 2025, the company operated or managed 80 23 skilled nursing facilities with 10,329 24 licensed beds, 26 25 assisted living facilities with 1,413 26 units, 9 27 independent living facilities with 777 28 retirement apartments, and 3 29 behavioral health hospitals with 102 30 licensed beds. For the year ended December 31, 2025, inpatient services generated net patient revenues of $1,315,545,000 31 and other revenues of $1,467,000 32, for total net operating revenues of $1,317,012,000 33. The segment reported income from operations of $127,751,000 34 for 2025. Occupancy rates for owned and leased skilled nursing facilities were 89.7% 35 in 2025, compared to 88.6% 36 in 2024 and 87.9% 37 in 2023. Assisted living occupancy was 84.3% 38 in 2025 versus 81.1% 39 in 2024, and independent living occupancy was 93.8% 40 in 2025 versus 93.2% 41 in 2024. The segment also includes rehabilitative services with a rehabilitation staff of over 1,230 42 therapists, medical specialty units including memory care and sub-acute nursing units, and pharmacy operations with five regional pharmacy locations 43.
NHC's homecare and hospice services segment includes 34 44 homecare agencies and 33 45 hospice agencies operating under the Caris Healthcare brand. For the year ended December 31, 2025, this segment generated net patient revenues of $154,086,000 46 and reported income from operations of $30,060,000 47. In 2025, homecare agencies served an average census of 3,834 48 patients and provided 339,344 49 visits. Hospice services, provided through Caris Healthcare, cared for over 1,647 50 patients per day across 33 51 locations in Georgia, Missouri, South Carolina, Tennessee, and Virginia. The I-SNP, NHC Advantage, operated in Tennessee, Missouri, and South Carolina with approximately 1,300 52 members enrolled as of December 31, 2025. Other revenue sources include management, accounting, and financial services provided to 11 53 healthcare facilities for management and 14 54 healthcare facilities for accounting and financial services as of December 31, 2025, rental income from 10 55 healthcare properties leased to third-party operators, and insurance services through two wholly-owned insurance subsidiaries providing workers' compensation and professional liability coverage.
On August 1, 2024, the Company purchased the assets of White Oak Management, Inc., a portfolio consisting of 15 56 skilled nursing facilities, two 57 assisted living facilities, four 58 independent living facilities, and a long-term care pharmacy, with 1,928 59 licensed skilled nursing beds, 48 60 assisted living units, and 302 61 independent living units in South Carolina and North Carolina. During 2025, the Company purchased 127,338 62 shares of its common stock for a total cost of $14,730,000 63. The Company also contributed land to a newly-formed limited liability company resulting in an equity interest; the fair value of the land contributed was $5,625,000 64 with a cost basis of $2,019,000 65, generating a gain of $3,606,000 66 netted within other operating expenses. Dividends declared per common share were $2.53 67 in 2025, compared to $2.42 68 in 2024 and $2.34 69 in 2023. The Company recorded $9,445,000 70 of government stimulus income related to the Employee Retention Credit in 2024. On July 29, 2025, NHI notified NHC of alleged non-compliance with certain non-monetary provisions of the Master Lease, and on September 8, 2025, NHI formally alleged a default; NHC disputes that any default has occurred 71.
For the fiscal year ended December 31, 2025, NHC reported total net operating revenues and stimulus income of $1,517,781,000 72, an increase of 16.1% 73 compared to $1,307,382,000 74 in 2024. Net income attributable to NHC was $120,015,000 75 in 2025, compared to $101,927,000 76 in 2024 and $66,798,000 77 in 2023. Diluted earnings per share were $7.67 78 in 2025, versus $6.53 79 in 2024 and $4.34 80 in 2023. Income from operations was $128,352,000 81 in 2025, compared to $89,895,000 82 in 2024 and $57,458,000 83 in 2023. The overall average census in owned and leased skilled nursing facilities improved to 89.7% 84 in 2025 from 88.6% 85 in 2024. The composite skilled nursing facility per diem increased 4.0% 86 in 2025 compared to 2024. Cash provided by operating activities was $185,078,000 87 in 2025, compared to $107,303,000 88 in 2024.
Business Outlook
A primary growth vector is the expansion of post-acute and senior healthcare operations through construction and acquisitions. Recent activities include the August 1, 2024 acquisition of the White Oak portfolio, which added 15 89 skilled nursing facilities, two 90 assisted living facilities, four 91 independent living facilities, and a long-term care pharmacy with 1,928 92 licensed skilled nursing beds, 48 93 assisted living units, and 302 94 independent living units in South Carolina and North Carolina. The company also opened new hospice agencies in Morristown, TN (April 2024), Lawrenceburg, TN (July 2024), Wytheville, VA (August 2024), and Clinton, TN (October 2024) 95. In 2023, NHC opened new assisted living facilities in Vero Beach, FL (135 units 96), Merritt Island, FL (95 units 97), and Stuart, FL (100 units 98), and acquired a skilled nursing facility with 66 99 beds in Nashville, TN. The company is also investing in joint venture multi-family developments under construction in Nashville, Tennessee, contributing capital of $5,629,000 100 in 2025.
Another growth vector is the expansion of the I-SNP, NHC Advantage, which restricts enrollment to Medicare Advantage eligible individuals who have had or are expected to need skilled nursing facility level of services for 90 days or longer 101. As of December 31, 2025, the I-SNP operated in Tennessee, Missouri, and South Carolina with approximately 1,300 102 members. The company believes the I-SNP benefits patients by providing nurse practitioners and care-coordination teams that enhance the patient-centered experience and quality of care 103. Additionally, NHC is in various stages of partnerships with hospital systems, payors, and other post-acute alliances to better position itself as an active participant in the delivery of post-acute healthcare services 104.
Management focuses on margin trajectory through labor cost control and operational efficiency. Salaries, wages, and benefits as a percentage of net operating revenues and stimulus income improved to 60.7% 105 in 2025 from 62.0% 106 in 2024. Agency nurse staffing expenses decreased $9,335,000 107, or approximately 66.6% 108, in 2025 compared to 2024, and decreased $19,962,000 109, or approximately 66.2% 110, in 2024 compared to 2023. Total costs and expenses as a percentage of net operating revenues and stimulus income improved to 91.6% 111 in 2025 from 93.1% 112 in 2024 and 94.9% 113 in 2023. Income from operations as a percentage of net operating revenues and stimulus income improved to 8.4% 114 in 2025 from 6.9% 115 in 2024 and 5.1% 116 in 2023. The company faces inflationary pressures in certain categories within other operating expenses, such as food/dietary supplies and drugs/pharmaceutical supplies 117.
The company is undertaking a process to allocate more aggressive capital spending within its owned and leased facilities to address issues arising from an aging physical plant 118. As of December 31, 2025, NHC leased or owned 72 119 skilled nursing facilities, 24 120 assisted living facilities, three 121 behavioral health hospitals, and eight 122 independent living facilities. The company continues to refine and implement information technology to improve customer service, enhance operating efficiencies, and provide more effective management of business operations 123. NHC had 15,278 124 full-time and part-time employees as of December 31, 2025, and faces competition in employing and retaining nurses, technicians, aides, and other high-quality professional and non-professional employees 125.
Capital allocation priorities include investing in property and equipment, share repurchases, and dividend payments. Cash used for property and equipment additions was $36,446,000 126 in 2025, $27,600,000 127 in 2024, and $27,901,000 128 in 2023. In 2025, the Company purchased 127,338 129 shares of its common stock for $14,730,000 130. The Company has paid a common dividend since 2004 131, with dividends declared per common share of $2.53 132 in 2025, $2.42 133 in 2024, and $2.34 134 in 2023. Dividends paid to common stockholders were $38,704,000 135 in 2025, $36,964,000 136 in 2024, and $35,560,000 137 in 2023. The Company has a $50 million 138 available line of credit and had borrowing capacity on that facility as of December 31, 2025. The Company also has unencumbered real estate assets that could potentially be used as collateral in future borrowing opportunities 139.
A significant headwind is the dispute with National Health Investors, Inc. (NHI) regarding the Master Lease covering a significant portion of NHC's skilled nursing and independent living facilities. On July 29, 2025, NHI notified NHC of alleged non-compliance with certain non-monetary provisions, and on September 8, 2025, NHI formally alleged a default based on four non-monetary provisions 140. NHC disputes that any default has occurred and continues to communicate with NHI to resolve these matters 141. In October 2025, NHC provided NHI with notice of intent to exercise its right to extend the Master Lease for an additional five-year term beginning January 1, 2027 142. Failure to resolve the disputes or secure renewal on acceptable terms could result in loss of the right to occupy and operate some or all affected facilities, or subject NHC to damages, acceleration of rent, or other remedies 143.
Structural headwinds include the ongoing healthcare labor shortage, which has amplified the challenge of maintaining desirable patient census levels 144. The company faces competition in employing and retaining qualified personnel, especially facility administrators, nurses, certified nurses' aides, and other important healthcare providers 145. The difficulty in hiring and retaining qualified personnel has increased average wage rates 146. Additionally, certain states have adopted minimum staffing standards, and failure to comply may result in fines or other sanctions 147. The company also faces uncertainty regarding Medicare and Medicaid reimbursement rates, with the Budget Control Act of 2011 imposing Medicare spending reductions of up to 2% 148 per fiscal year, extended through 2030 149. CMS projects payments to home health agencies in fiscal year 2026 will decrease by 1.3% 150 or $220 million 151 relative to the prior year.
Risk Factors
NHC derives a substantial portion of revenue from Medicare and Medicaid, and changes in reimbursement rates or methods could materially reduce revenues and operating margins. The Budget Control Act of 2011 imposes Medicare spending reductions of up to 2% 152 per fiscal year, extended through 2030 153. CMS projects a 1.3% 154 decrease, or $220 million 155, in home health payments for fiscal year 2026. The dispute with NHI over the Master Lease creates significant uncertainty; NHI formally alleged a default based on four non-monetary provisions on September 8, 2025 156, and failure to resolve could result in loss of the right to occupy and operate some or all affected facilities 157. The company is largely self-insured for professional liability and workers' compensation, with accrued risk reserves totaling $121,595,000 158 at December 31, 2025. Unfavorable claims activity resulted in additional other operating expenses of $17,563,000 159 in 2025 compared to 2024. The company faces a highly competitive labor market with a shortage of nurses and other key personnel, which has increased average wage rates and resulted in agency nurse staffing expenses, though these decreased by $9,335,000 160 or 66.6% 161 in 2025. The investment portfolio is concentrated in NHI common stock, which comprised $124,532,000 162, or 69.1% 163, of the total fair value of marketable equity securities at December 31, 2025, creating concentration risk.
Management Priorities
Management's tone in the filing is focused on operational improvement, quality of care, and strategic growth. Key themes include the continued increase in skilled nursing census, per diem increases from governmental payors, the reduction of agency staffing expense, and the accretive contribution of the White Oak acquisition. Management emphasizes that the company has always strived for patient-centered care and quality outcomes as precursors to outstanding financial performance 164. Specific forward-looking statements include the estimate that the Tennessee Medicaid increase effective July 1, 2025 will result in approximately $3,000,000 165 annually, or $750,000 166 per quarter, and the South Carolina Medicaid increase effective October 1, 2025 will result in approximately $4,200,000 167 annually, or $1,050,000 168 per quarter. Management also notes that the fiscal year 2026 CMS rule for skilled nursing facilities equates to a net 3.2% 169 increase in Medicare Part A payments, and the hospice payment update includes a 2.6% 170 rate increase, or $750 million 171. Strategic priorities emphasized include expanding post-acute and senior healthcare operations while protecting existing operations and markets, linking skilled nursing facilities with senior living communities, home health, hospice, and behavioral health hospitals to obtain a competitive advantage 172, and working internally to improve systems to be most responsive to referral sources and payors while finding creative initiatives to retain and attract qualified healthcare professionals 173.
View Source Annual Report on SEC.gov ↗
References
- [1] Item 1, Business — Description of the Business
- [2] Item 1, Business — Competition
- [3] Item 1, Business — Competition
- [4] Item 1, Business — Quality of Patient Care
- [5] Item 1, Business — Quality of Patient Care
- [6] Item 1, Business — Quality of Patient Care
- [7] Item 1, Business — Description of the Business
- [8] Item 1, Business — Quality of Patient Care
- [9] Item 1A, Risk Factors — If we fail to compete effectively
- [10] Item 7, MD&A — Results of Operations
- [11] Item 1, Business — Other Revenues
- [12] Item 1, Business — Description of the Business
- [13] Item 1, Business — Description of the Business
- [14] Item 1, Business — Description of the Business
- [15] Item 1, Business — Description of the Business
- [16] Item 1, Business — Description of the Business
- [17] Item 1, Business — Description of the Business
- [18] Item 1, Business — Description of the Business
- [19] Item 1, Business — Description of the Business
- [20] Item 1, Business — Description of the Business
- [21] Item 1, Business — Net Patient Revenues
- [22] Item 1, Business — Institutional Special Needs Plan
- [23] Item 1, Business — Description of the Business
- [24] Item 1, Business — Description of the Business
- [25] Item 1, Business — Description of the Business
- [26] Item 1, Business — Description of the Business
- [27] Item 1, Business — Description of the Business
- [28] Item 1, Business — Description of the Business
- [29] Item 1, Business — Description of the Business
- [30] Item 1, Business — Description of the Business
- [31] Item 7, MD&A — Segment Reporting
- [32] Item 7, MD&A — Segment Reporting
- [33] Item 7, MD&A — Segment Reporting
- [34] Item 7, MD&A — Segment Reporting
- [35] Item 7, MD&A — Executive Summary
- [36] Item 7, MD&A — Executive Summary
- [37] Item 7, MD&A — Executive Summary
- [38] Item 1, Business — Assisted Living Facilities
- [39] Item 1, Business — Assisted Living Facilities
- [40] Item 1, Business — Independent Living Facilities
- [41] Item 1, Business — Independent Living Facilities
- [42] Item 1, Business — Rehabilitative Services
- [43] Item 1, Business — Pharmacy Operations
- [44] Item 1, Business — Description of the Business
- [45] Item 1, Business — Description of the Business
- [46] Item 7, MD&A — Segment Reporting
- [47] Item 7, MD&A — Segment Reporting
- [48] Item 1, Business — Homecare Agencies
- [49] Item 1, Business — Homecare Agencies
- [50] Item 1, Business — Hospice Agencies
- [51] Item 1, Business — Hospice Agencies
- [52] Item 1, Business — Institutional Special Needs Plan
- [53] Item 1, Business — Management, Accounting and Financial Services
- [54] Item 1, Business — Management, Accounting and Financial Services
- [55] Item 1, Business — Rental Income
- [56] Item 1, Business — Development and Growth
- [57] Item 1, Business — Development and Growth
- [58] Item 1, Business — Development and Growth
- [59] Item 1, Business — Development and Growth
- [60] Item 1, Business — Development and Growth
- [61] Item 1, Business — Development and Growth
- [62] Item 5, Market for Registrant's Common Equity — Stock Repurchase Programs
- [63] Item 5, Market for Registrant's Common Equity — Stock Repurchase Programs
- [64] Item 7, MD&A — 2025 Compared to 2024
- [65] Item 7, MD&A — 2025 Compared to 2024
- [66] Item 7, MD&A — 2025 Compared to 2024
- [67] Item 8, Financial Statements — Consolidated Statements of Operations
- [68] Item 8, Financial Statements — Consolidated Statements of Operations
- [69] Item 8, Financial Statements — Consolidated Statements of Operations
- [70] Item 1, Business — Government Stimulus Income
- [71] Item 1A, Risk Factors — The status of our lease with National Health Investors, Inc.
- [72] Item 8, Financial Statements — Consolidated Statements of Operations
- [73] Item 7, MD&A — 2025 Compared to 2024
- [74] Item 8, Financial Statements — Consolidated Statements of Operations
- [75] Item 8, Financial Statements — Consolidated Statements of Operations
- [76] Item 8, Financial Statements — Consolidated Statements of Operations
- [77] Item 8, Financial Statements — Consolidated Statements of Operations
- [78] Item 8, Financial Statements — Consolidated Statements of Operations
- [79] Item 8, Financial Statements — Consolidated Statements of Operations
- [80] Item 8, Financial Statements — Consolidated Statements of Operations
- [81] Item 8, Financial Statements — Consolidated Statements of Operations
- [82] Item 8, Financial Statements — Consolidated Statements of Operations
- [83] Item 8, Financial Statements — Consolidated Statements of Operations
- [84] Item 7, MD&A — Executive Summary
- [85] Item 7, MD&A — Executive Summary
- [86] Item 7, MD&A — 2025 Compared to 2024
- [87] Item 8, Financial Statements — Consolidated Statements of Cash Flows
- [88] Item 8, Financial Statements — Consolidated Statements of Cash Flows
- [89] Item 1, Business — Development and Growth
- [90] Item 1, Business — Development and Growth
- [91] Item 1, Business — Development and Growth
- [92] Item 1, Business — Development and Growth
- [93] Item 1, Business — Development and Growth
- [94] Item 1, Business — Development and Growth
- [95] Item 1, Business — Development and Growth
- [96] Item 1, Business — Development and Growth
- [97] Item 1, Business — Development and Growth
- [98] Item 1, Business — Development and Growth
- [99] Item 1, Business — Development and Growth
- [100] Item 7, MD&A — Investing Activities
- [101] Item 1, Business — Institutional Special Needs Plan
- [102] Item 1, Business — Institutional Special Needs Plan
- [103] Item 1, Business — Institutional Special Needs Plan
- [104] Item 7, MD&A — Executive Summary
- [105] Item 7, MD&A — Results of Operations
- [106] Item 7, MD&A — Results of Operations
- [107] Item 7, MD&A — 2025 Compared to 2024
- [108] Item 7, MD&A — 2025 Compared to 2024
- [109] Item 7, MD&A — 2024 Compared to 2023
- [110] Item 7, MD&A — 2024 Compared to 2023
- [111] Item 7, MD&A — Results of Operations
- [112] Item 7, MD&A — Results of Operations
- [113] Item 7, MD&A — Results of Operations
- [114] Item 7, MD&A — Results of Operations
- [115] Item 7, MD&A — Results of Operations
- [116] Item 7, MD&A — Results of Operations
- [117] Item 7, MD&A — 2024 Compared to 2023
- [118] Item 1A, Risk Factors — Upkeep of healthcare properties is capital intensive
- [119] Item 1A, Risk Factors — Upkeep of healthcare properties is capital intensive
- [120] Item 1A, Risk Factors — Upkeep of healthcare properties is capital intensive
- [121] Item 1A, Risk Factors — Upkeep of healthcare properties is capital intensive
- [122] Item 1A, Risk Factors — Upkeep of healthcare properties is capital intensive
- [123] Item 1A, Risk Factors — Implementation of new information technology
- [124] Item 1, Business — Human Capital
- [125] Item 1, Business — Human Capital
- [126] Item 7, MD&A — Investing Activities
- [127] Item 7, MD&A — Investing Activities
- [128] Item 7, MD&A — Investing Activities
- [129] Item 5, Market for Registrant's Common Equity — Stock Repurchase Programs
- [130] Item 5, Market for Registrant's Common Equity — Stock Repurchase Programs
- [131] Item 5, Market for Registrant's Common Equity — Dividend Policy
- [132] Item 8, Financial Statements — Consolidated Statements of Operations
- [133] Item 8, Financial Statements — Consolidated Statements of Operations
- [134] Item 8, Financial Statements — Consolidated Statements of Operations
- [135] Item 8, Financial Statements — Consolidated Statements of Cash Flows
- [136] Item 8, Financial Statements — Consolidated Statements of Cash Flows
- [137] Item 8, Financial Statements — Consolidated Statements of Cash Flows
- [138] Item 7, MD&A — Short-term liquidity
- [139] Item 7, MD&A — Long-term liquidity
- [140] Item 1A, Risk Factors — The status of our lease with National Health Investors, Inc.
- [141] Item 1A, Risk Factors — The status of our lease with National Health Investors, Inc.
- [142] Item 1A, Risk Factors — The status of our lease with National Health Investors, Inc.
- [143] Item 1A, Risk Factors — The status of our lease with National Health Investors, Inc.
- [144] Item 7, MD&A — Executive Summary
- [145] Item 1A, Risk Factors — The cost to replace or retain qualified nurses
- [146] Item 1A, Risk Factors — The cost to replace or retain qualified nurses
- [147] Item 1A, Risk Factors — The cost to replace or retain qualified nurses
- [148] Item 1A, Risk Factors — We depend on reimbursement from Medicare, Medicaid and other third-party payors
- [149] Item 1A, Risk Factors — We depend on reimbursement from Medicare, Medicaid and other third-party payors
- [150] Item 1, Business — Homecares
- [151] Item 1, Business — Homecares
- [152] Item 1A, Risk Factors — We depend on reimbursement from Medicare, Medicaid and other third-party payors
- [153] Item 1A, Risk Factors — We depend on reimbursement from Medicare, Medicaid and other third-party payors
- [154] Item 1, Business — Homecares
- [155] Item 1, Business — Homecares
- [156] Item 1A, Risk Factors — The status of our lease with National Health Investors, Inc.
- [157] Item 1A, Risk Factors — The status of our lease with National Health Investors, Inc.
- [158] Item 7, MD&A — Accrued Risk Reserves
- [159] Item 7, MD&A — 2025 Compared to 2024
- [160] Item 7, MD&A — 2025 Compared to 2024
- [161] Item 7, MD&A — 2025 Compared to 2024
- [162] Item 7A, Quantitative and Qualitative Disclosure About Market Risk
- [163] Item 7A, Quantitative and Qualitative Disclosure About Market Risk
- [164] Item 1, Business — Quality of Patient Care
- [165] Item 1, Business — Medicaid Legislation and Regulations
- [166] Item 1, Business — Medicaid Legislation and Regulations
- [167] Item 1, Business — Medicaid Legislation and Regulations
- [168] Item 1, Business — Medicaid Legislation and Regulations
- [169] Item 1, Business — Medicare Legislation and Regulations
- [170] Item 1, Business — Hospice
- [171] Item 1, Business — Hospice
- [172] Item 1, Business — Competition
- [173] Item 7, MD&A — Executive Summary
- [174] Item 8, Financial Statements — Consolidated Statements of Operations
- [175] Item 8, Financial Statements — Consolidated Statements of Operations
- [176] Item 8, Financial Statements — Consolidated Statements of Operations
- [177] Item 8, Financial Statements — Consolidated Statements of Operations
- [178] Item 8, Financial Statements — Consolidated Statements of Operations
- [179] Item 8, Financial Statements — Consolidated Statements of Operations
- [180] Item 8, Financial Statements — Consolidated Statements of Operations
- [181] Item 8, Financial Statements — Consolidated Statements of Operations
- [182] Item 8, Financial Statements — Consolidated Statements of Operations
- [183] Item 8, Financial Statements — Consolidated Statements of Operations
- [184] Item 8, Financial Statements — Consolidated Statements of Operations
- [185] Item 8, Financial Statements — Consolidated Statements of Operations
- [186] Item 8, Financial Statements — Consolidated Statements of Cash Flows
- [187] Item 8, Financial Statements — Consolidated Statements of Cash Flows
- [188] Item 8, Financial Statements — Consolidated Statements of Cash Flows
- [189] Item 8, Financial Statements — Consolidated Statements of Cash Flows
- [190] Item 8, Financial Statements — Consolidated Statements of Cash Flows
- [191] Item 8, Financial Statements — Consolidated Balance Sheets
- [192] Item 8, Financial Statements — Consolidated Balance Sheets
- [193] Item 8, Financial Statements — Consolidated Balance Sheets
- [194] Item 8, Financial Statements — Consolidated Balance Sheets
- [195] Item 8, Financial Statements — Consolidated Balance Sheets
- [196] Item 8, Financial Statements — Consolidated Balance Sheets
- [197] Item 8, Financial Statements — Consolidated Statements of Operations
- [198] Item 7, MD&A — 2025 Compared to 2024
- [199] Item 8, Financial Statements — Consolidated Statements of Operations
- [200] Item 7, MD&A — 2024 Compared to 2023
- [201] Item 8, Financial Statements — Consolidated Statements of Operations
- [202] Item 8, Financial Statements — Consolidated Statements of Operations
- [203] Item 7, MD&A — 2025 Compared to 2024
- [204] Item 1, Business — Government Stimulus Income
- [205] Item 8, Financial Statements — Consolidated Statements of Operations
- [206] Item 7, MD&A — Segment Reporting
- [207] Item 7, MD&A — Segment Reporting
- [208] Item 7, MD&A — Segment Reporting
- [209] Item 7, MD&A — Segment Reporting
Analysis on 6/9/2026